"L’Institut d’Investigació Biomèdica de Girona (IDIBGI) és un centre d’investigació CERCA de la Generalitat de Catalunya, i que té com a finalitat promoure, desenvolupar, gestionar, transferir i difondre la recerca biomèdica, coneixement científic i tecnològic, la docència i la formació en l’àmbit de les ciències de la vida i de la salut, principalment a l’entorn de Girona. Constituït formalment al 2005 l’institut té els seus orígens en la Fundació Privada Dr. Josep Trueta (1995) i des de l’any 2008 té caràcter públic, amb l’entrada de la Generalitat en els òrgans de govern."

During the past decade, Institut d'Investigació Biomèdica de Girona (IDIBGI) conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut d'Investigació Biomèdica de Girona (IDIBGI)" #1 collaborator was "Cellnovo Limited" with 2 trials as a collaborator, "Imperial College London" with 2 trials as a collaborator, "Oxford Brookes University" with 2 trials as a collaborator, "Romsoft SRL" with 2 trials as a collaborator and "Universitat de Girona" with 2 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Institut d'Investigació Biomèdica de Girona (IDIBGI)" are "Obesity" (3 trials), "Diabetes Mellitus, Type 1" (2 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Institut d'Investigació Biomèdica de Girona (IDIBGI)" in a lesser frequency.

Most popular intervention types in "Institut d'Investigació Biomèdica de Girona (IDIBGI)" are "Device" (2 trials), "Procedure" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bariatric Surgery" (2 trials), "PEPPER system" (2 trials) and "Metformin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut d'Investigació Biomèdica de Girona (IDIBGI)" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Institut d'Investigació Biomèdica de Girona (IDIBGI)". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institut d'Investigació Biomèdica de Girona (IDIBGI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut d'Investigació Biomèdica de Girona (IDIBGI), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".